Article Details
Retrieved on: 2021-06-21 05:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Finally, Truist Securities reissued a "hold" rating and set a $20.00 target price on shares of Translate Bio in a report on Wednesday, March 24th.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here